Deborah Birx - 14 Mar 2026 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Chief Executive Officer, Director
Signature
/s/ Deborah Birx
Issuer symbol
ARMP
Transactions as of
14 Mar 2026
Net transactions value
$0
Form type
4
Filing time
17 Mar 2026, 19:46:39 UTC
Previous filing
11 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Birx Deborah Chief Executive Officer, Director 5005 MCCONNELL AVENUE, LOS ANGELES /s/ Deborah Birx 17 Mar 2026 0001849673

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ARMP Common Stock Tax liability -4,919 -2.3% $10.54* 212,458 14 Mar 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Company to satisfy its income tax and withholding remittance obligations in connection with the net settlement of restricted stock units.